Gelonghui, May 13 | Freda (600223.SH) said on an interactive platform that the company's Shandong Focus Freda Biology Co., Ltd. is one of the world's leading production bases for hyaluronic acid, integrating R&D, production and sales of hyaluronic acid. The company's subsidiary Shandong Freda Biotechnology Co., Ltd. mainly develops, produces and sells food additives and cosmetic ingredients. The sodium hyaluronate and derivatives of Shandong Focus Freda Biology Co., Ltd., the full range of products of Shandong Freda Biotechnology Co., Ltd., and collagen and hyaluronic acid-related products of Shandong Freda Biology Co., Ltd. all use biological fermentation technology. The company built a joint laboratory with Jiangnan University in 2020. After recent years of development, hyaluronic acid production strains and hyaluronidase efficient expression strains were successfully constructed using synthetic biology technology, and hyaluronidase was successfully applied to the precise control of hyaluronic acid with different molecular weights and the preparation of small enzymatic cleavage molecules, and jointly developed derivatives such as acetylated hyaluronic acid.
福瑞达(600223.SH)：利用合成生物学技术成功构建透明质酸生产菌株和透明质酸酶高效表达菌株
Freda (600223.SH): Successful construction of hyaluronic acid production strains and hyaluronidase efficient expression strains using synthetic biology technology
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.